Novocol Healthcare, a subsidiary of Septodont, acquires device company Duoject

Novocol Healthcare Inc. (NHI) expands injectable capabilities with a strategic investment in device company Duoject. NHI parent company, Septodont, a leader in dental local anesthetics, looks to benefit.

Nov 3rd, 2015
Content Dam Diq En Articles Apex360 2015 11 Novocol Healthcare A Subsidiary Of Septodont Acquires Device Company Duoject Leftcolumn Article Thumbnailimage File

Novocol Healthcare Inc. (NHI) expands injectable capabilities with a strategic investment in device company Duoject. NHI parent company, Septodont, a leader in dental local anesthetics, looks to benefit.

Last week,Novocol Healthcare Inc. (NHI), a subsidiary of Septodont Inc., announced the acquisition of a majority stake in Duoject Medical Systems Inc. (Duoject), a supplier of innovative medical devices. According to a press release issued by NHI, the acquisition will maximize synergy between the companies and add value to NHI development projects.

The acquisition will allow NHI to offer a broad array of injection devices and reconstitution systems to its pharmaceutical filling customers. Todd Beechey, President of NHI, commented, “The acquisition of Duoject enables NHI to offer a more complete and differentiated line of drug filling and delivery solutions to our customers. The acquisition of Duoject transforms NHI’s injectable business from a sterile injectable filling company to a one-stop source for device design and development, and pharmaceutical filling and supply of unique injectable products.”

NHI corporate summary

NHI focuses on partnering with pharmaceutical and device companies to utilize its specialized manufacturing capabilities. NHI collaborates with large multinational partners as well as niche companies to bring significant differentiation to their development projects and commercial products. Through its sister-company, Novocol Pharmaceutical of Canada Inc., NHI offers manufacturing expertise in areas that include sterile filling of cartridges and delivery for semi-solid dosages such as creams, ointments, topical solutions, and gels.

Duoject corporate summary

Duoject is a supplier of innovative medical devices and design and development services, located in Québec, Canada. With expertise in design innovation, Duoject's technologies provide customers the ability to manage and extend product life cycles and differentiate product offerings in competitive markets.

Source: NHI press release, 26 October 2015

--------------------------------------------------

Related:Dentsply acquires Sirona

--------------------------------------------------

Editor's note: This article first appeared in the Apex360e-newsletter. Receive your free subscriptionhere.

More in Industry